 Home > Medical News >

Medical Science News

Genfit's double agonist was awarded orphan drug status by the FDA and EMA

 Time of Update: 2021-02-24

peru drug tissue evaluating margin safety drug stronger morphine bzd drug

April 2019, the FDA also awarded Elafibranor Breakthrough Drug Qualification (BTD) for the treatment of adult PBC patients who did not respond well to UDCA. Genfit plans to launch Phase III clinical studies in 2019 to further evaluate the efficacy and safety of elafibranor's treatment of PBC.
Puma Biotech Licensing Partners are market-licensed by Nerlynx

 Time of Update: 2021-02-24

capsaicin weight loss cipro skin infections 1 3 cyclohexanedione common drug allergies ttf 1 positive

Puma Biotechnology corporation announced that the Argentine Medicines, Food and Medical Devices Authority (ANMAT) has approved Nerlynx (neranib) to extend complementary treatment for adult patients w
FDA approves new antimicrobial drugs to treat complex urinary tract infections

 Time of Update: 2021-02-24

gas cylinder safety silicone food safe lipitor drug interactions safety hazard definition resin drug

The U.S. Food and Drug Administration recently approved cefiderocol, an antimicrobial drug used to treat patients 18 years of age or older with complex urinary tract infections (cUTI), including kidney infections caused by susceptible Gloran-negative microorganisms, who have limited or no other treatment options.
FDA approves Lilly Taltz (ixekizumab) treatment for active orthodlamitis

 Time of Update: 2021-02-24

positive sweat test anti nuclear ab strong anti inflammatory normal freezing point parkinson's treatment drug

In the ixekizumab group of COAST-V and COAST-W trials, 48% and 25% of patients reached the main endpoint ASASAS40, respectively, while the placebo group achieved 18% and 13%, respectively.
CHMP recommends approval of Trogarzo for multidrring-resistant TREATMENT of HIV-1

 Time of Update: 2021-02-24

fenofibrate 48 mg drug weights allegra drug interactions hsv 1 infection tecfidera mechanism action

Trogarzo is the first approved single anti-drug in the field of HIV treatment, and the first long-acting new drug for HIV, unlike other antiretroviral drugs, which are mainly combined with the second extracellular domain of CD4-T cellular mediators, far from the MHC II molecular binding site, which can potentially prevent HIV from infecting CD4-plus immune cells while retaining normal immune function.
FDA approves first treatment for patients with rare lung disease

 Time of Update: 2021-02-24

mdma drug test propranolol drug ether drug trulicity injection side effects drug inc show

Recently, the U.S. Food and Drug Administration approved Gifraj to treat acute hepatodiasis in adults, a genetic disorder that can lead to the accumulation of toxic molybrene molecules formed during the production of hemoerin (which helps bind oxygen to the blood).
FDA approves new treatment for migraines in adults

 Time of Update: 2021-02-24

meropenem side effects mupirocin 2 percent acrylamide side effects 1 2 epoxypentane spiriva side effects

U.S. Food and Drug Administration recently approved Ubrivevy tablets for acute (immediate) treatment of migraines in adults, with or without precursors (sensory phenomena or visual impairments), and Ubrelvy was not used to prevent migraines.
Lilly announces the survival benefits of the new drug Verzenio

 Time of Update: 2021-02-24

data analysis biology aquatic development group metastatic gastric cancer used nascar parts advanced control

The drug is the first and only CDK4 and 6 inhibitors used in combination with fluovirus groups, and based on phase III MONARCH 2 studies, there is a significant statistical improvement in total survival rates in patients/post-menoanth and post-menoanthetic women who progress after endocrine therapy for cancer.
Non-diabetic patients had a 27% reduced risk of heart failure, and AZ published a net detailed Phase 3 result for Dagly

 Time of Update: 2021-02-24

ginseng blood pressure 1 2 block mold 1 control mustard blood pressure mupirocin 2 percent

AstraZeneca has published detailed results from its SGLT2 inhibitor Farxiga (dapagliflozin) in a Phase 3 clinical trial for patients with heart failure at the Annual Meeting of the European Society of Cardiology (ESC2019).
Gilead published clinical data on GS-9688, a new functional drug for hepatitis B

 Time of Update: 2021-02-24

zoloft drug benadryl drug test topamax drug class flonase drug class non 24 drug

In a multi-center, randomized, double-blind Phase II study of 48 patients with chronic HBV infections who had achieved virological suppression, GS-9688 (once a week oral) combined oral antiviral drugs (OAVs) were well toned during extended administration and showed pharmacological activity of dose dependence.
Takeda protease inhibitor Ninlaro Phase 3 test reached the main end of the test

 Time of Update: 2021-02-24

cell activity free multiple drug used treat syphilis mcf7 cell line mm4

Today, Takeda announced that its protease inhibitor Ninlaro (ixazomib) as a first-line maintenance therapy, in the treatment of adult patients with multiple myeloma (MM) who have not received stem cell transplant therapy in phase 3 trials, the patient's progression-free survival (PFS) has been significantly improved to reach the main end of the trial.
Novart confirms The long-term efficacy and safety of Emwave

 Time of Update: 2021-02-24

100 benefits canada drug com anti allergic drugs www drug com sign

new data from Novarma confirm the long-term efficacy and safety of erenumab for most people with seizure migraines. The pharmaceutical giant announced the results of a five-year open-label treatme
Roche's new drug Gazyva treats lupus nephritis CRR up to 40%

 Time of Update: 2021-02-24

iv anti inflammatory biofilm phase 2 advanced arimistane side effects roflumilast side effects new drugs market

November 11, Roche announced that its small-molecule drug for SMA, Risdiplam and CD20 monoantigen Gazyva, had achieved positive results in phase III SUNFISH studies and Phase II NOBILITY studies, respectively.
Turalio, a new drug used to treat tendon cytoblastoma, has been approved by the FDA for the first time

 Time of Update: 2021-02-24

stiffness stroud water research center food products international terlipressin fda approval proteins found body

the U.S. Food and Drug Administration (FDA) approved Dayichi Sankyo's Pexidartinib capsule for the treatment of adult patients with tendon cytomoma (TGCT) symptoms, who are associated with severe morbidity or functional limitations and have not improved through surgery.
Johnson and Johnson submitted an application for an Ebola vaccine to the EMA

 Time of Update: 2021-02-24

food safety alert food safety software scientific applications specialist based food safety tips

Johnson and Johnson announced that it would submit its Ebola vaccine research program to the European Medicines Agency (EMA) for a listing permit.
The ground-breaking PCSK9-targeted RNAi drug inclisiran III was successfully studied

 Time of Update: 2021-02-24

2 1 4 mm plantago major uses mao inhibitors natural dexamethasone 10 mg chemical safety symbols

This is the second of three key Phase III clinical studies (ORION-9, ORION-10, ORION-11) of the drug, which showed that 300mg inclisiran was given 2 subsurfic injections a year, reaching all major and secondary endpoints, with good tolerance and safety.
The FDA has awarded AstraZeneta Imfinzi an orphan drug to treat small cell lung cancer

 Time of Update: 2021-02-24

primary tissue types advanced infigratinib fda approval flouride cause cancer new immunotherapy drugs

Based on this result, Imfinzi became the first immunotherapy to be shown to have a three-year survival benefit in the non-excisive Phase III NSCLC population.
Xofluza: An effective anti-flu drug

 Time of Update: 2021-02-24

4 16 reduced 1 2 butadiene roche fda approved epoxy bauer 1 2 impact

. Roche announced that in the IIIBLOCKSTONE study, the risk of influenza was significantly reduced by 86% compared to placebo, using Xofluza for preventive treatment after contact with infected family members.
FDA approves first treatment of patients with rare blood diseases

 Time of Update: 2021-02-24

echinacea drug interactions high pressure pneumatics drug hair sample eltrombopag side effects ibandronate side effects

recently, the U.S. Food and Drug Administration approved luspatercept-aamt treatment for adults who require routine red blood cell infusions β “ When a patient receives multiple blood transfusions, there is a risk of iron overload, which affects many organs," said Dr. Richard Pazdur, director of the FDA Center of Excellence in Oncology and acting director of the U.S. Food and Drug Administration's Office of Oncology at the Center for Drug Evaluation and Research.
FDA approves Xeris ready-to-use liquid glucreatic glucemic Gvoke

 Time of Update: 2021-02-24

par 4 success antwerpen auto group group 4 guardian drug company market data

Xeris Pharmaceuticals Inc. announced Tuesday that the U.S. Food and Drug Administration has approved Gwalk (gluatic glucin) for the treatment of severe hypoglycemia in children and adults 2 years of age and older with diabetes.

Go to Page

Medical Science News

Genfit's double agonist was awarded orphan drug status by the FDA and EMA

Puma Biotech Licensing Partners are market-licensed by Nerlynx

FDA approves new antimicrobial drugs to treat complex urinary tract infections

FDA approves Lilly Taltz (ixekizumab) treatment for active orthodlamitis

CHMP recommends approval of Trogarzo for multidrring-resistant TREATMENT of HIV-1

FDA approves first treatment for patients with rare lung disease

FDA approves new treatment for migraines in adults

Lilly announces the survival benefits of the new drug Verzenio

Non-diabetic patients had a 27% reduced risk of heart failure, and AZ published a net detailed Phase 3 result for Dagly

Gilead published clinical data on GS-9688, a new functional drug for hepatitis B

Takeda protease inhibitor Ninlaro Phase 3 test reached the main end of the test

Novart confirms The long-term efficacy and safety of Emwave

Roche's new drug Gazyva treats lupus nephritis CRR up to 40%

Turalio, a new drug used to treat tendon cytoblastoma, has been approved by the FDA for the first time

Johnson and Johnson submitted an application for an Ebola vaccine to the EMA

The ground-breaking PCSK9-targeted RNAi drug inclisiran III was successfully studied

The FDA has awarded AstraZeneta Imfinzi an orphan drug to treat small cell lung cancer

Xofluza: An effective anti-flu drug

FDA approves first treatment of patients with rare blood diseases

FDA approves Xeris ready-to-use liquid glucreatic glucemic Gvoke